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A 28-year-old sub-Saharan African Italian non-smoker male presented with signs and symptoms of
pneumonia and respiratory failure. Despite antibiotic treatment he experienced a signiﬁcant worsening
of respiratory conditions and admission to intensive care unit. He thus underwent chest computed to-
mography followed by ﬁberopict bronchoscopy with bronchoalveolar lavage whose macroscopic ex-
amination led to the diagnosis of acute chest syndrome. A brief literature review was conducted to
discuss the ﬁrst manifestation of this disease.
© 2017 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Clinical case
A 28-year-old sub-Saharan African Italian non-smoker male
presented in late November 2016 to the Emergency Room of the
University Hospital of Modena for the gradual onset of shortness of
breath, fever and mild chest pain. The past medical history was
silent. At the physical examination, bilateral posterior crackles were
detected. Arterial blood gas analysis was performed and revealed
acute hypoxic respiratory failure. He underwent a chest X-ray
showing posterior lower bilateral consolidations (Fig. 1A). He was
then admitted to the Respiratory Diseases Unit where antibiotic
course with amoxicillin/clavulanate and oxygen therapy were
started. During hospital stay he experienced a signiﬁcant wors-
ening of the hypoxic respiratory failure, thus chest Computed To-
mography (CT) scan was performed. It showed bi-basal posterior
consolidation with attenuate air bronchogram and mild pericardial
effusion (Fig.1B). Hewas admitted to the Respiratory Intensive Care
Unit (ICU) where he underwent ﬁberoptic bronchoscopy (FOB)
with bronchoalveolar lavage (BAL) whose sample presented with a
light yellow appearance (Fig. 1C). The peculiar appearance of the
BAL ﬂuid, associated to the patient ethnicity suggested the hy-
pothesis of a pulmonary manifestation of sickle cell disease. We
performed a hemoglobin (Hb) electrophoresis test and a hetero-
zygosis condition for b S globin chain with C Hb was reported; thus
the diagnosis of sickle cell-Hb SC disease was made andi).
n open access article under the CChydroxyurea was started with rapid improvement of respiratory
failure and symptoms.2. Discussion
Acute chest syndrome (ACS) is a major cause of hospitalization
and ICU admission in patients with sickle cell disease [1]. It requires
clinical awareness because of its potentially life-threatening com-
plications, which can lead to refractory hypoxemia and death [2].
Different pathologic mechanisms affecting sickle cell have been
hypothesized as causal factors for the occurrence of ACS. While
lung infections were initially recognized as a major cause for the
onset of respiratory failure and symptoms in sickle cell patients,
further investigations identiﬁed parenchymal infarction related to
in-situ thromboembolism, hypoventilation due to painful chest
wall lesions, intravascular overload and fat embolism syndrome as
important factors in determining and precipitating ACS [3]. The
presence of a yellowish plasma-like coloration of the BAL ﬂuid,
namely known as “golden BAL ﬂuid”, is a pathognomonic sign of
ACS. The nature of this particular appearance was commonly
attributed to the presence of bilirubin in alveolar spaces due to
injury-related increased capillary endothelial permeability [4,5].
More recently Contou et al. analyzed the BAL ﬂuid of 3 patients
experiencing ACS showing that the yellowish stain was related to
an intense exudative process with increased levels of proteins and
lactate dehydrogenase rather than to bilirubin content [6]. What
seems peculiar in our case was that ACS appeared to be the ﬁrst
manifestation of the underlying hemoglobinopathy. Moreover it is
worth to say that the incidence of ACS is lower for Hb SC genotypeBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. A. Chest X ray in lateral view showing posterior basal consolidations. B. Chest CT scan depicting bilateral lung base consolidation. C. Light yellow stain bronchoalveolar lavage
ﬂuid.
L. Fabbri et al. / Respiratory Medicine Case Reports 22 (2017) 51e5252as compared to Hb SS or Hb S ß0-thalassemia [5,7]. In conclusionwe
would like to stress the attention on an uncommon cause of
pneumonia, whose bronchoalveolar manifestation could be of
paramount importance for its correct diagnosis.
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